A. Cabral

发表

The antiphospholipid/cofactor syndromes.

D. Alarcón-Segovia, A. Cabral, 1996, The Journal of rheumatology.

The antiphospholipid/cofactor syndromes: a primary variant with antibodies to beta 2-glycoprotein-I but no antibodies detectable in standard antiphospholipid assays.

D. Alarcón-Segovia, M. Amigo, A. Cabral, 1996, The American journal of medicine.

Anti-citrullinated peptide antibodies in lupus patients with or without deforming arthropathy

J. Cabiedes, A. Cabral, GN Damián-Abrego, 2008, Lupus.

Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions

Y. Shoenfeld, G. Espinosa, R. Cervera, 2011, Lupus.

Will some day PAPS fade into SLE?

D. Alarcón-Segovia, A. Cabral, D. Alarcon-segovia, 1996, Lupus.

Tween 20 detaches cardiolipin from ELISA plates and makes anticardiolipin antibodies undetectable regardless of the presence of beta 2-glycoprotein-I.

D. Alarcón-Segovia, J. Cabiedes, A. Cabral, 1994, Journal of immunological methods.

Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.

D. Alarcón-Segovia, A. Cabral, J. Cabiedes, 1995, The Journal of rheumatology.

Hemolytic anemia related to an IgM autoantibody to phosphatidylcholine that binds in vitro to stored and to bromelain-treated human erythrocytes.

D. Alarcón-Segovia, A. Cabral, J. Cabiedes, 1990, Journal of autoimmunity.

Antibodies to phospholipid-free beta 2-glycoprotein-I in patients with primary antiphospholipid syndrome.

D. Alarcón-Segovia, A. Cabral, J. Cabiedes, 1995, The Journal of rheumatology.

Assessment of healing phenomena in rheumatoid arthritis: comment on the article by Rau and Herborn.

D. Alarcón-Segovia, A. Cabral, 1996, Arthritis and rheumatism.

Functional and immunochemical heterogeneity of antiphospholipid antibodies: a classification.

D. Alarcón-Segovia, A. Cabral, D. Alarcon-segovia, 1992, The Journal of rheumatology.

The anti-phospholipid antibody syndrome: clinical and serological aspects.

D. Alarcón-Segovia, A. Cabral, 2000, Bailliere's best practice & research. Clinical rheumatology.

The Concept and Classification of Antiphospholipid/Cofactor Syndromes

D. Alarcón-Segovia, A. Cabral, D. Alarcon-segovia, 1996, Lupus.

Clinical, histopathological, immunological and fibroblast studies in 30 patients with subcutaneous injections of modelants including silicone and mineral oils.

D. Alarcón-Segovia, J. Alcocer-Varela, R. Orozco‐Topete, 1994, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion.

Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (II): thrombocytopenia and skin manifestations

Y. Shoenfeld, G. Espinosa, R. Cervera, 2011, Lupus.

Autoantibodies in systemic lupus erythematosus.

D. Alarcón-Segovia, A. Cabral, D. Alarcon-segovia, 1996, Current opinion in rheumatology.

Detection of anticardiolipin antibodies in heat-inactivated normal human sera is not influenced by beta 2-glycoprotein-I.

D. Alarcón-Segovia, J. Cabiedes, A. Cabral, 1993, Thrombosis research.

Antiphospholipid antibodies in patients with idiopathic autoimmune haemolytic anemia.

D. Alarcón-Segovia, J. Cabiedes, A. Cabral, 1994, Autoimmunity.

Phospholipid specificity and requirement of beta 2-glycoprotein-I for reactivity of antibodies from patients with primary antiphospholipid syndrome.

J. Sánchez-Guerrero, D. Alarcón-Segovia, J. Cabiedes, 1992, Journal of autoimmunity.

Heterogeneity of antibodies to β2-glycoprotein 1 from patients with systemic lupus erythematosus

D. Alarcón-Segovia, A. Cabral, J. Cabiedes, 2004 .

Autoantibodies in systemic lupus erythematosus.

D. Alarcón-Segovia, A. Cabral, 1998, Current opinion in rheumatology.

Antiphospholipid antibodies. Where do they come from? Where do they go?

D. Alarcón-Segovia, A. Cabral, 1994, The Journal of rheumatology.

Identification of four subpopulations of IgG anticardiolipin antibodies in patients with primary antiphospholipid syndrome on the basis of their requirement for beta 2-glycoprotein-I and their unmasking by heat.

D. Alarcón-Segovia, J. Cabiedes, A. Cabral, 1994, Clinical and experimental rheumatology.

Bone remodeling and osteophyte formation after remission of rheumatoid arthritis.

D. Alarcón-Segovia, A. Cabral, B. Loya, 1989, The Journal of rheumatology.

The history of antimalarials.

D. Wallace, A. Cabral, D. Alarcón-Segovia, 1996, Lupus.